Image source: Getty Images When looking for the best stocks to buy in the month ahead, I often start by checking what just happened in the one we’re just leaving behind. One FTSE 100 name jumped out at me. Retail giant Next (LSE: NXT) ended October almost 17% higher, comfortably ahead of the second-best performer, drug maker GSK. I already hold GSK in my Self-Invested Personal Pension but sadly, I don’t hold Next. Probably because I never quite believed my eyes whenever I looked at its performance. Retail is supposed to be a disaster zone. Whole chains have collapsed under the weight of the cost-of-living crisis,…
Author: user
Image source: Getty Images Heading into November, I have been looking for some possible dividend shares to help boost my passive income streams. Not only have I been looking in the flagship FTSE 100 index of leading companies, I have also been hunting in the FTSE 250. Here are three FTSE shares, each yielding over 7%, that I think investors should consider. ITV: 7.2% Broadcaster ITV (LSE: ITV) needs little introduction, as it has been a staple of national life for decades. It still earns significant revenue from its legacy broadcasting operations. But in recent years it has also expanded…
Image source: Getty Images As I type, Amazon (NASDAQ:AMZN) shares are up 12% today (31 October), and that’s good news for a couple of FTSE 100 investment trusts. Especially as Amazon stock is now at a new all-time high. These are benefitting The FTSE 100 investment trusts alluded to are Pershing Square Holdings (LSE:PSH) and Scottish Mortgage Investment Trust (LSE:SMT). Both have Amazon as one of their top holdings. To be fair, that wouldn’t be hard for Pershing Square, which gives everyday investors access to Bill Ackman’s hedge fund portfolio. By default, any stock that makes the cut is a…
Image source: Getty Images The appeal of penny shares for investors is often the hope of buying something for much less than it is worth. One share in my portfolio typifies that right now, I reckon. Logistics Development Group (LSE: LDG) has a share price of around 14p. But its net asset value (NAV) per share, at the end of June, was 26.7p per share. Can that really be the possible bargain it seems? Value is locked up, for now There are a couple of points it is helpful to understand. That NAV estimate is already from a few months…
Image source: Getty Images With the FTSE 100 at a record high, it’s become a bit trickier to spot undervalued UK stocks. Therefore, it might be a good idea to look at unloved sectors, as many shares in these will be down by default. Babies being thrown out with the bath water, as it were. Some unloved areas right now include renewable energy, small-caps, REITs, housebuilders, and retail stocks. There will undoubtedly be lucrative opportunities hiding in plain sight in these spaces. For me though, one sector that looks undervalued from a long-term perspective is healthcare. This area’s been shunned…
Image source: Getty Images FTSE 100 dividend income stocks are a wonder to behold. Some yield as much as 7% or 8% a year, and that’s only part of their charm. When conditions are right, they can also generate plenty of capital growth on top. Investors shouldn’t expect them to behave like whizzy growth shares though. Their capital returns tend to come in bursts, and there are times when prices will stagnate or fall. Yet with luck, the dividends should keep rolling in, and if reinvested the returns can compound nicely over time. No guarantees, of course, which is why it…
Image source: Getty Images A stock jumped 14% in my ISA portfolio yesterday (30 October). Normally this would be great, but strangely I felt nothing. That’s because the share — Moderna (NASDAQ:MRNA) — was already struggling badly. In fact, even after this double-digit rise, I’m still down 78% on my investment. It’s fitting that it’s Halloween today, because this one has been a horror show for me. But at least it might now be coming to an end. Pipeline problems Moderna made a fortune from its mRNA vaccine during the pandemic. With this windfall, it invested heavily to develop and…
Image source: Getty Images The Apple (NASDAQ: AAPL) after-hours share price was in sprightly form as investors reacted to an(other) encouraging set of quarterly numbers from the US tech titan on Thursday (30 October). Revenue came in at $102.5bn. That’s an increase of 8% on that achieved one year ago. But it was also a bit higher than analysts had been expecting. As normal, iPhone sales made up a significant proportion of that figure. Their contribution of $49bn was an improvement of roughly 6% on the previous financial year. And Apple’s bottom line? Well, profit hit $27.5bn. No wonder it…
Image source: Getty Images With November almost upon us, now is a time when many investors will be considering what moves to make in their ISA or Self-Invested Personal Pension (SIPP). Here are a couple of shares I think investors should consider in the coming month. Greggs High street baker Greggs (LSE: GRG) has thousands of shops, a loyal customer following and compelling value proposition for customers. Still, that has not been enough to help bolster the share price lately. Greggs shares are now 41% below where they started the year. That means Greggs now trades on a price-to-earnings ratio…
Image source: Getty Images A couple of years ago, I added a brilliant FTSE 100 income share to my Self-Invested Personal Pension (SIPP). Yet at the time, investors didn’t seem to think it was so brilliant. The shares were struggling, and the yield appeared too good to be true at around 10%. Sky-high rates of income are often a warning sign. Yields are calculated by dividing the dividend per share by the share price. When the share price falls the dividend soars through simple maths. This can also leave the board scrambling to generate enough cash to satisfy investors. if…